LEGN

LEGEND BIOTECH CORP-ADR

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

LEGEND BIOTECH CORP-ADR (LEGN) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$292.38M; the largest are Zhang Lei, Steven Cohen, Renaissance Technologies. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 added, 3 trimmed, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Cooling

Common-stock holders51 also report options

Congress trades0

Price$18.62vs quarter-end-35.53%

Sectors4

This quarter's moves

New0

Added1

Trimmed / sold4

Top holder

Zhang Lei

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Zhang LeiHold

Value $172.83M20.8% of portfolio5,984,5502026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Zhang Lei	2026 Q2	$172.83M	5,984,550	20.8%	Hold

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinPUT—

Value $4.01M— of portfolio138,9002026 Q2

Ken GriffinCALL—

Value $3.35M— of portfolio115,9002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken GriffinPUT	2026 Q2	$4.01M	138,900	—	—
Ken GriffinCALL	2026 Q2	$3.35M	115,900	—	—

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.